Somerset Pharmaceuticals
Somerset Pharma LLC is an American pharmaceutical company dedicated to manufacturing and supplying affordable generic medicines across various therapeutic segments. Founded in 2013 by Dr. Veerappan Subramanian and Dr. Ilango Subramanian, the company focuses on developing and commercializing generic injectable and ophthalmic products in the US. With a strong presence in retail and hospital sectors, Somerset Pharma emphasizes quality and affordability to make healthcare more accessible and sustainable. The company is expanding its infrastructure, including new manufacturing facilities in Bengaluru and New Jersey, and invests heavily in research and development to innovate in various dosage forms. Somerset Pharma is committed to improving patient care and has a strict anti-capital punishment policy regarding its products.
Industries
Nr. of Employees
small (1-50)
Somerset Pharmaceuticals
Patents
Methods of efficiently treating vitamin C deficiency-related diseases and other conditions
US-12097178-B2
View DetailsOphthalmic gel compositions of bimatoprost and timolol and associated methods
US-12064440-B2
View Details
Methods of efficiently treating vitamin C deficiency-related diseases and other conditions
US-12097178-B2
View DetailsOphthalmic gel compositions of bimatoprost and timolol and associated methods
US-12064440-B2
View DetailsProducts
Injectable sterile products
Parenteral formulations provided in vials, ampoules and pre-filled syringes, including lyophilized and liquid presentations.
Ophthalmic products
Sterile ophthalmic formulations supplied in droppers and ophthalmic bottles.
Oral solids
Manufacture and supply of oral solid dosage forms such as capsules and tablets.
Solution dosage forms
Liquid solution formulations for various therapeutic uses.
Injectable sterile products
Parenteral formulations provided in vials, ampoules and pre-filled syringes, including lyophilized and liquid presentations.
Ophthalmic products
Sterile ophthalmic formulations supplied in droppers and ophthalmic bottles.
Oral solids
Manufacture and supply of oral solid dosage forms such as capsules and tablets.
Solution dosage forms
Liquid solution formulations for various therapeutic uses.
Services
End-to-end manufacturing and supply of generic pharmaceutical products across multiple dosage forms for retail and hospital customers.
Sales and account management services focused on institutional customers, GPO and IDN contract negotiation and product conversion for hospital and state facility procurement.
Formulation development, pre-formulation analysis, analytical development and scale-up support for complex dosage forms and advanced delivery technologies.
End-to-end manufacturing and supply of generic pharmaceutical products across multiple dosage forms for retail and hospital customers.
Sales and account management services focused on institutional customers, GPO and IDN contract negotiation and product conversion for hospital and state facility procurement.
Formulation development, pre-formulation analysis, analytical development and scale-up support for complex dosage forms and advanced delivery technologies.
Expertise Areas
- Sterile manufacturing (injectables and ophthalmics)
- Formulation development for complex and advanced drug delivery systems
- Analytical development and microbiology testing
- Regulatory compliance with US FDA requirements
Key Technologies
- Aseptic processing
- Terminal sterilization
- Lyophilization (freeze-drying)
- Automated vial/ampoule filling lines
News & Updates
Somerset Therapeutics Private Limited facility receives EIR from USFDA
The Somerset Therapeutics Private Limited facility received the Establishment Inspection Report from USFDA.
Meeting the Industry
Conferences are an opportunity for Somerset Pharma to interact with customers.
First launch of 2023 - Ropivacaine Hydrochloride Injection
Introduction of a new variant of Ropivacaine Injection 2mg/mL, expanding the anesthesia product portfolio.
Exciting Update @ Somerset, 6 New Products Launched in record time
The company launched six new products including Cupric Chloride, Acetylcysteine Injection, Midazolam Injection, Hydroxyurea Capsules, Timolol Maleate OS, and Potassium Phosphate.
Sample Injectables post 1
Details about Suamtriptan Injection USP, a product offered by Somerset Pharma.
Cisatracurium Besylate for Injection, USP
Information about the product Cisatracurium Besylate for Injection, USP.
Somerset Therapeutics Private Limited facility receives EIR from USFDA
The Somerset Therapeutics Private Limited facility received the Establishment Inspection Report from USFDA.
Meeting the Industry
Conferences are an opportunity for Somerset Pharma to interact with customers.
First launch of 2023 - Ropivacaine Hydrochloride Injection
Introduction of a new variant of Ropivacaine Injection 2mg/mL, expanding the anesthesia product portfolio.
Exciting Update @ Somerset, 6 New Products Launched in record time
The company launched six new products including Cupric Chloride, Acetylcysteine Injection, Midazolam Injection, Hydroxyurea Capsules, Timolol Maleate OS, and Potassium Phosphate.
Sample Injectables post 1
Details about Suamtriptan Injection USP, a product offered by Somerset Pharma.
Cisatracurium Besylate for Injection, USP
Information about the product Cisatracurium Besylate for Injection, USP.